Global Health: Managing Risk, Financing Transition, and Driving Growth
Session Overview
Global Health: Managing Risk, Financing Transition, and Driving Growth
Global health sits at a crossroads. Geopolitical fragmentation, tightening public budgets, and shifting political priorities are placing a growing strain on health systems worldwide, even as health remains a critical driver of economic growth, workforce participation, and productivity. Long-standing models of cooperation and financing are under pressure at a moment when demand for resilience, access, and sustainability is increasing.
This session brings together four focused conversations that examine how global health is being reshaped in practice. The panels explore how partnerships are evolving in a more fragmented global landscape, what pharmaceutical sovereignty means for regions seeking greater resilience, where health financing pressures are building most acutely, and why treating health as an economic engine, rather than a cost, has become central to long-term growth and stability. Together, these discussions assess what is working, where current models are under strain, and how policy, financing, and market choices made today will shape the future of global health and economic resilience.
You can also join the event via livestream at undavos.com/streaming
What’s Next for Global Health: Navigating a New Landscape
The global health landscape is being reshaped by geopolitical tensions, shifting funding priorities, and uneven recovery from recent shocks. Long-standing models of cooperation are under strain, even as demand for coordinated action on health security, access, and equity continues to grow. This session will bring together senior leaders to examine how partnerships across governments, multilateral institutions, philanthropy, and industry are evolving in response to these pressures. The discussion will focus on where collaboration remains essential, where roles are changing, and how the private sector can contribute to progress in a more fragmented global environment.
Host / Speakers
Laura Herman — Partner, Global Lead Responsible Business Practice Dalberg Advisors
Dr. Leslie Ramsammy — Ambassador and Permanent Representative Cooperative Republic of Guyana
Monica Sanders — Board Member, Society for Family Health, Rwanda Society for Family Health, Rwanda
Marie-Ange Saraka-Yao — Chief Mobilization and Growth Officer Gavi, The Vaccine Alliance
Dr. Priya Agrawal — VP of Health Equity and Partnerships Merck (MSD)
From Cholera to Ebola: A New Partnership Model to Advance Local Vaccine Ecosystems in LMICs
As the demand for quality healthcare surges in low- and middle-income countries yet global aid dollars decrease, how do we meet this moment in ways that protect human health, support local economic growth and leverage the best of cross-sector collaboration?
In this moderated fireside chat, the leaders of Hilleman Labs (joint venture backed by Wellcome and MSD) and CEPI discuss how true ecosystem partnerships across the whole value chain work together to advance much- needed vaccines while creating skilled jobs and driving local prosperity.
As part of this discussion, a new strategic partnership will be announced that points the way toward a transformative shift in the way that we meet emerging health threats and foster market growth in low- and middle-income countries.
Host / Speakers
Laura Herman — Partner, Global Lead Responsible Business Practice Dalberg Advisors
Dr. Raman Rao — CEO Hilleman Labs
Dr. Richard Hatchett — CEO Coalition for Epidemic Preparedness Innovations (CEPI)
Scaling Innovation: Implementation in Times of Uncertainty
Across global health, innovation is not the primary constraint. Implementation at scale is. Many solutions demonstrate impact in pilots yet struggle to expand across countries, systems, and populations amid geopolitical uncertainty, constrained financing, and fragmented delivery environments. This session brings together leaders from consumer health, medical technology, primary care, and global health delivery to examine what it takes to implement and scale innovation in real-world settings. The discussion will focus on the operating principles, trade-offs, and system enablers that determine whether innovations translate into sustained population-level impact, including how organizations balance efficiency with resilience, standardization with local adaptation, and speed with equity.
Host / Speakers
Lily Chhatwal — Principal, Health Practice Global Co-Lead Dalberg Advisors
Esha Gupta — Head of Global Public Health and Social Impact Colgate-Palmolive
Charles-Antoine Janssen — Co-Founder & Managing Partner HealthKois
Patrick Sieyes — Director of Strategic Partnerships and External Affairs Vastergaard
Bjoern von Siemens — Founder & President Caresyntax
Health Financing at Risk: Geopolitics, Markets, and Policy at a Turning Point
Global health financing is entering a period of heightened uncertainty. Geopolitical fragmentation, evolving trade and pricing policies, fiscal constraints, and shifting public-sector priorities are placing increasing strain on health systems worldwide. These pressures are particularly acute for countries striving to sustain progress toward universal health coverage amid rising costs and growing demand. This session will convene senior decision-makers to assess how geopolitical forces are reshaping health financing markets and policy choices, and to examine the role of innovative financing mechanisms, public-private collaboration, and policy alignment in navigating this turning point.
Host / Speakers
Andrea Feigl — Senior Director Deloitte
Dr. Asif Dhar — Global Consulting Services (GCS) Growth Leader Deloitte
Christophe Weber — President, CEO and Representative Director Takeda Pharmaceuticals
Stefan Weber — VP and Head of Global Policy, Advocacy and Health Equity AstraZeneca
Dan Vahdat — CEO Huma Therapeutics
Gargee Ghosh — President of Global Policy and Advocacy Gates Foundation
Health@Davos
Where health innovation meets system implementation to improve patient outcomes.
Now in its fourth year, Health@Davos has become one of the most prominent convenings outside the formal Davos programme, bringing together senior leaders from government, global health institutions, philanthropy, industry, and frontline organisations. Led by Dalberg and unDavos, the event provides a trusted space for practical discussion on building resilient and equitable health systems during a period of global change.
This year's programme focuses on the shifting global health landscape, the future of health financing, and why health must be understood as a core driver of economic growth. Health@Davos is part of a week-long collaboration with the Health Equity Lounge (HEAL), extending the conversation across multiple sessions and formats throughout Davos Week.